Hybrigenics has appointed Anne-Fabienne Weitsch to the position of chief operating officer, the Paris-based functional proteomics company said last week. Weitsch, who most recently served at Johnson & Johnson as senior director of licensing and business development, will be responsible for all aspects of Hybrigenics’ management, business development and drug discovery activities, the company said.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.